GAMs are recruited via glioma-derived chemo-attractants, including CCL2 (306), CCL7 (307), CX3CL1 (308), and stromal-derived factor-1 (SDF-1) (309); GAMs are subsequently sustained within tissue via glioma-derived growth factors, such as CSF-1, G-CSF, and hepatocyte growth factor (310–312). Here, CX3CL1 is linked to central nervous system cancer.